← Eichor
Condition: Pharmacokinetic Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Pharmacokinetic

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
Phase 1 · 1 location(s) · Brigham and Women's Hospital · NCT05069688Population Pharmacokinetics and Pharmacodynamics of Ciprofol
Phase N/A · 1 location(s) · Shanghai Geriatric Medical Center · NCT07301242A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · 2 location(s) · Vibrant Sciences Limited · NCT07222969A Clinical Study of AK0610
Phase 1 · 1 location(s) · Shanghai Ark Biopharmaceutical Co., Ltd. · NCT06996704An Open-Label, Two-Cohort, Pharmacokinetic Study in a Maximal Use Setting for Patients With Actinic Keratosis on the Upp
Phase 1 · 1 location(s) · Sun Pharmaceutical Industries Limited · NCT07729579A Study of CTD402 in T-ALL/LBL Patients
Phase 1/Phase 2 · 8 location(s) · Imviva Bio · NCT07070219A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies
Phase 1 · 1 location(s) · Nanjing Chia-tai Tianqing Pharmaceutical · NCT06049667Safety, Tolerability, PK and PD of SSS55 in Healthy Subjects
Phase 1 · 1 location(s) · Shenyang Sunshine Pharmaceutical Co., LTD. · NCT07058779To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults
Phase 1 · 1 location(s) · Hyundai Pharm · NCT06578676A Phase I Clinical Study to Evaluate the Safety, Tolerability, and PK of HLX48 in Advanced/Metastatic Solid Tumors
Phase 1 · 7 location(s) · Shanghai Henlius Biotech · NCT07473726A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopen
Phase 2/Phase 3 · 20 location(s) · argenx · NCT07194850A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia: Pharmacokinetic Study
EARLY_Phase 1 · 1 location(s) · Woolcock Institute of Medical Research · NCT06801379A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of
Phase 1/Phase 2 · 12 location(s) · Ipsen · NCT07213817Phase 1 Study of Intravaginal KB15A
Phase 1 · 1 location(s) · ZabBio Inc. · NCT07222020A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Canc
Phase 1 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT06500052Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML
Phase 1/Phase 2 · 12 location(s) · Ascentage Pharma Group Inc. · NCT04501120A Study of Zovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy Participants
Phase 1 · 3 location(s) · Beijing QL Biopharmaceutical Co.,Ltd · NCT07443059A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects
Phase 1/Phase 2 · 4 location(s) · Clearmind Medicine Inc. · NCT05913752Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia
Phase 1/Phase 2 · 1 location(s) · Luye Pharma Group Ltd. · NCT06731868EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid Tumors
Phase 1 · 11 location(s) · Epics Therapeutics · NCT07163325A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Su
Phase 1 · 1 location(s) · Boryung Pharmaceutical Co., Ltd · NCT07069335A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults
Phase 1 · 1 location(s) · Shanghai World Leader Pharmaceutical Co., Ltd. · NCT07465965A Study of HDM2024 in Participants With Advanced Solid Tumors
Phase 1 · 1 location(s) · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · NCT07539285A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Parti
Phase 1 · 3 location(s) · Comanche Biopharma · NCT07282171A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer
Phase 2 · 2 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT07230106An European Multi-centre Cohort Study for Unravelling Pharmacokinetic and Genetic Factors Underlying Post-ERCP Pancreati
Phase N/A · 1 location(s) · Radboud University Medical Center · NCT05267379A Phase I Study of SIM0388 in Participants With Malignant Ascites.
Phase 1 · 1 location(s) · Jiangsu Simcere Pharmaceutical Co., Ltd. · NCT07007988RC48-ADC Combined With Radiotherapy in the Treatment of Locally Advanced Solid Tumors With HER2 Expression
Phase 1 · 1 location(s) · RemeGen Co., Ltd. · NCT05940896Evaluating a Potential Pharmacokinetic Kratom-oxycodone Interaction Concurrent With Clinical Endpoints
EARLY_Phase 1 · 1 location(s) · Washington State University · NCT05846451Effects of Feel Free® Classic Tonic on Stress and Pharmacokinetics in Healthy Adults
NA · 1 location(s) · Botanic Tonics, LLC · NCT07469527
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.